Journal Information
Vol. 15. Issue 6.
Pages 567-572 (November - December 2011)
Share
Share
Download PDF
More article options
Vol. 15. Issue 6.
Pages 567-572 (November - December 2011)
Original article
Open Access
Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina
Visits
2580
Gerardo Daniel Deluca1,
Corresponding author
delucagd@gmail.com

Correspondence to: Gerardo Daniel Deluca Roldán 1307 (CP:3500) Resistencia, Chaco, Argentina.
, Jorge Basiletti2, Eduardo Schelover3, Nicolás Díaz Vásquez4, José Mario Alonso5, Héctor Marcelo Marín6, Raúl Horacio Lucero7, María Alejandra Picconi8
1 Faculty of Medicine, Northeast National University, Corrientes, Argentina
2 Researcher, Oncogenic Virus Service, National Reference Laboratory on Human Papillomavirus, National Institute of Infectious Diseases “Carlos G. Malbrán”, Buenos Aires, Argentina
3 Institute of Regional Medicine, Northeast National University, Chaco, Argentina
4 Institute of Regional Medicine, Northeast National University, Chaco, Argentina
5 Head of the Immunology Service, Institute of Regional Medicine, Northeast National University, Chaco, Argentina
6 Researcher, Molecular Biology Laboratory, Institute of Regional Medicine, Northeast National University, Chaco, Argentina
7 Head of the Molecular Biology Laboratory, Institute of Regional Medicine, Northeast National University, Chaco, Argentina
8 Head of the Oncogenic Virus Service, National Reference Laboratory on Human Papillomavirus, National Institute of Infectious Diseases “Carlos G. Malbrán”, Buenos Aires, Argentina
This item has received

Under a Creative Commons license
Article information
Abstract
Objectives

High-risk types of human papillomavirus (HPV) are strongly associated with cervical cancer (CC), and Chlamydia trachomatis (CT), the most frequent sexually transmitted bacterial infection (STBI) worldwide, seems to be a risk factor for HPV infection and for CC. It is also known that both agents are more prevalent in vulnerable communities where lack of adequate primary health care is a cause for concern. The aim of this work was to determine the impact of CT and HPV infections in women belonging to an isolated aboriginal population (Pilaga community) from a poor region in Northern Argentina (province of Formosa). For this purpose, a cross-sectional study was performed in all sexually active Pilaga women, who attended a local community-based gynecological health screening project. The polymerase chain reaction (PCR) method on a cervical brush specimen was used to detect both agents.

Results

A total of 227 women (20% of the total female population of the Pilaga community) were studied and the overall prevalence was 26.4% for CT, 46.7% for HPV and 16.3% for concurrent infection. CT infection was higher in HPV DNA positive (34.2%) than in HPV DNA negative women (19%; OR: 2.22/95% CI=1.16-4.28/p=0.009) and the most prevalent HPV types were HPV-16 (19.4%), 6 and 18 (5.3%), 58 (3.5%) and 33 (3.1%).

Conclusions

The prevalence of CT and HPV observed in Pilaga women are among the worst registered in Latin America. Also, data collected suggest that chlamydial infection may play an important role in the natural history of HPV infection. On this respect, we propose that the association between these two agents seems to be more related to a mutual potentiation than to the fact that they share a common route of transmission.

Keywords:
Chlamydia trachomatis
papillomavirus infections
indigenous population
uterine cervical diseases
Full text is only aviable in PDF
References
[1]
World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections-Overview and estimates [Internet]. Geneva; 2001. Available from: http://www.who.int/hiv/pub/sti/who_hiv_aids_2001.02.pdf.
[2]
W.E. Stamm, et al.
Chlamydia trachomatis infections of the adult.
Sexually transmitted diseases, pp. 575-594
[3]
W.E. Stamm.
Chlamydia trachomatis – the persistent pathogen: Thomas Parran Award Lecture.
Sex Transm Dis, 28 (2001), pp. 684-689
[4]
J.S. Smith, C. Bosetti, N. Muñoz, et al.
Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study.
Int J Cancer, 111 (2004), pp. 431-439
[5]
Lehtinen M, Ault KA, Lyytikainen E, et al. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect [Internet]. 2011; Available from: http://www.ncbi.nlm.nih.gov/pubmed/21471141.
[6]
M.L. Oliveira, M.M.R. Amorim, P.R.E. Souza, et al.
Chlamydia infection in patients with and without cervical intra-epithelial lesions tested by real-time PCR vs. direct immunofluorescence.
Braz J Infect Dis, 12 (2008), pp. 324-328
[7]
I. Silins, W. Ryd, A. Strand, et al.
Chlamydia trachomatis infection and persistence of human papillomavirus.
Int J Cancer, 116 (2005), pp. 110-115
[8]
J.S. Smith, N. Muñoz, R. Herrero, et al.
Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines.
J Infect Dis, 185 (2002), pp. 324-331
[9]
A.C. Simonetti, J.H. Melo, L. de, P.R.E. de Souza, et al.
Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor.
Microbes Infect, 11 (2009), pp. 435-442
[10]
F.X. Bosch, A.N. Burchell, M. Schiffman, et al.
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
[11]
M. Schiffman, P.E. Castle, J. Jeronimo, et al.
Human papillomavirus and cervical cancer.
[12]
S.K. Kjaer, A.J.C. van den Brule, G. Paull, et al.
Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.
BMJ, 325 (2002), pp. 572
[13]
G.Y. Ho, R.D. Burk, S. Klein, et al.
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.
J Natl Cancer Inst, 87 (1995), pp. 1365-1371
[14]
M. Almonte, G. Albero, M. Molano, et al.
Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean.
[15]
P.K. Drain, K.K. Holmes, J.P. Hughes, et al.
Determinants of cervical cancer rates in developing countries.
Int J Cancer, 100 (2002), pp. 199-205
[16]
Arrossi S. Proyecto para el mejoramiento del Programa Nacional de Prevención de Cáncer de Cuello Uterino en Argentina. Informe final: Diagnóstico de situación del Programa Nacional y Programas Provinciales [Internet]. 1st ed. Buenos Aires: Organización Panamericana de la Salud, OPS; 2008. Available from: http://www.msal.gov.ar/cancercervico- uterino/pdf/pub64_ops.pdf.
[17]
J.B. Mahony, K.E. Luinstra, J.W. Sellors, et al.
Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in firstvoid urine from asymptomatic and symptomatic men.
J Clin Microbiol, 30 (1992), pp. 2241-2245
[18]
H.U. Bernard, S.Y. Chan, M.M. Manos, et al.
Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms.
J Infect Dis, 170 (1994), pp. 1077-1085
[19]
M.M. Manos, Y. Ting, D.K. Wright, et al.
The use of polymerase chain reaction amplification for the detection of genital human papillomavirus.
Cancer Cells, 7 (1989), pp. 209-214
[20]
S. Franceschi, J.S. Smith, A. van den Brule, et al.
Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study.
Sex Transm Dis, 34 (2007), pp. 563-569
[21]
S.R. León, K.A. Konda, J.D. Klausner, et al.
Chlamydia trachomatis infection and associated risk factors in a low-income marginalized urban population in coastal Peru.
Rev Panam Salud Publica, 26 (2009), pp. 39-45
[22]
T.M.A. Martínez, S.I. Reid, C. Arias, et al.
Prevalence of cervical infection by Chlamydia trachomatis among Chilean women living in the Metropolitan Region.
Rev Med Chil, 136 (2008), pp. 1294-1300
[23]
M.M. Rodrigues, Fernandes PÁ, J.P. Haddad, et al.
Frequency of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis and Ureaplasma species in cervical samples.
J Obstet Gynaecol, 31 (2011), pp. 237-241
[24]
C. Santos, F. Teixeira, A. Vicente, et al.
Detection of Chlamydia trachomatis in endocervical smears of sexually active women in Manaus-AM, Brazil, by PCR.
Braz J Infect Dis, 7 (2003), pp. 91-95
[25]
J.S. Wilson, E. Honey, A. Templeton, et al.
A systematic review of the prevalence of Chlamydia trachomatis among European women.
Hum Reprod Update, 8 (2002), pp. 385-394
[26]
M.A. de Cristófano, B. Livellara, M.A. Galli, et al.
Extent of endemic Chlamydia trachomatis in the metropolitan area of Buenos Aires (Argentina).
Enferm Infecc Microbiol Clin, 15 (1997), pp. 134-139
[27]
S. Di Bartolomeo, M. Rodríguez, D. Sauka, et al.
Microbiologic profile in symptomatic pregnant women's genital secretions in Gran Buenos Aires, Argentina.
Enferm Infecc Microbiol Clin, 19 (2001), pp. 99-102
[28]
C.D. Golijow, M.C. Abba, S.A. Mourón, et al.
Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women.
Gynecol Oncol, 96 (2005), pp. 181-186
[29]
S. de Sanjosé, M. Diaz, X. Castellsagué, et al.
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.
Lancet Infect Dis, 7 (2007), pp. 453-459
[30]
G. Clifford, S. Gallus, R. Herrero, et al.
Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.
[31]
S.A. Tonon, M.A. Picconi, J.B. Zinovich, et al.
Prevalence of cervical infection by human papilloma virus (HPV) in the Caucasian and Guaraní populations residing in the province of Misiones, Argentina.
Rev Argent Microbiol, 35 (2003), pp. 205-213
[32]
M.A. Picconi, J. Gronda, L.V. Alonio, et al.
Human papilloma virus in Quechua women from Jujuy with high frequency of cervical cancer: viral types and HPV-16 variants.
Medicina (B Aires), 62 (2002), pp. 209-220
[33]
E. Matos, D. Loria, G.M. Amestoy, et al.
Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study.
Sex Transm Dis, 30 (2003), pp. 593-599
[34]
C.C. Sijvarger, J.V. González, A. Prieto, et al.
Cervical infection epidemiology of human papillomavirus in Ushuaia, Argentina.
Rev Argent Microbiol, 38 (2006), pp. 19-24
[35]
V. Verhoeven, M. Baay, J. Weyler, et al.
Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour.
Eur J Clin Microbiol Infect Dis, 23 (2004), pp. 735-737
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
The Brazilian Journal of Infectious Diseases
Article options
Tools